Get started
Author

Ting‐Ting Han

Observed names: T T Han, Ting-Ting Han, Ting-ting Han, Tingting Han, Ting‐ting Han
ORCID: 0000-0001-5047-9249
Observed ORCID: 0000-0001-5047-9249
OpenAlex ID: A5101717591
Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia
2016 · L P Xu, X H Zhang, et al. · Bone Marrow Transplantation · 86
G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
2019 · Qi Wen, Yuan Kong, et al. · Bone Marrow Transplantation · 69
Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation
2018 · Chen-Hua Yan, Yu Wang, et al. · Clinical Infectious Diseases · 66
PDF
Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation
2019 · Haixia Fu, Xiaohui Zhang, et al. · Bone Marrow Transplantation · 51
Cytomegalovirus is a potential risk factor for late‐onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation
2013 · Ting‐Ting Han, Lan‐Ping Xu, et al. · American Journal of Hematology · 47
An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation
2018 · Hong‐Yan Zhao, Zhong‐Shi Lyu, et al. · British Journal of Haematology · 42
Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial
2014 · Ting-ting Han, Lan-ping Xu, et al. · Annals of Hematology · 38
In vivo G-CSF treatment activates the GR-SOCS1 axis to suppress IFN-γ secretion by natural killer cells
2022 · Xiangyu Zhao, Ting Peng, et al. · Cell Reports · 30
Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation
2020 · Chen-Hua Yan, Yu Wang, et al. · Bone Marrow Transplantation · 27
Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
2024 · Haixia Fu, Xueyan Sun, et al. · BMC Medicine · 26
PDF
Mini-dose methotrexate combined with methylprednisolone as a first-line treatment for acute graft-versus-host disease: A phase 2 trial
2023 · Zhengli Xu, Xiaodong Mo, et al. · Journal of Translational Internal Medicine · 26
PDF
Quantity and Quality Reconstitution of NKG2A+ Natural Killer Cells Are Associated with Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
2018 · Li-Juan Hu, Xiang-Yu Zhao, et al. · Transplantation and Cellular Therapy · 26
PDF
Recipient‐donor KIR ligand matching prevents CMV reactivation post‐haploidentical T cell‐replete transplantation
2017 · Xiang‐Yu Zhao, Xue‐Yi Luo, et al. · British Journal of Haematology · 26
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia
2020 · Zheng‐Li Xu, Yi‐Fei Cheng, et al. · Clinical Transplantation · 25
Graft Failure in Patients With Hematological Malignancies: A Successful Salvage With a Second Transplantation From a Different Haploidentical Donor
2021 · Yu-Qian Sun, Yu Wang, et al. · Frontiers in Medicine · 24
PDF
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT
2022 · Ze-Ying Fan, Ting-Ting Han, et al. · Clinical & Experimental Immunology · 23
PDF
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation
2019 · Zheng-Li Xu, Lan-Ping Xu, et al. · Bone Marrow Transplantation · 19
Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key
2013 · Haixia Fu, Lanping Xu, et al. · International Journal of Hematology · 18
Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients
2022 · Rui-Xin Deng, Xiao-Lu Zhu, et al. · Transplantation and Cellular Therapy · 17
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
2022 · Xing-Xing Yu, Qian-Nan Shang, et al. · JCI Insight · 17
PDF
Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study
2021 · Yu-Qian Sun, Ting-Ting Han, et al. · Frontiers in Oncology · 17
PDF
Expanded clinical-grade NK cells exhibit stronger effects than primary NK cells against HCMV infection
2023 · Qian-Nan Shang, Xing-Xing Yu, et al. · Cellular and Molecular Immunology · 16
PDF
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment
2022 · Chen‐hua Yan, Yu Wang, et al. · 癌症：英文版 · 16
PDF
The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
2022 · Fan Lin, Tingting Han, et al. · Frontiers in Immunology · 16
PDF
Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia
2020 · Yan-Ru Ma, Wen-Jing Wang, et al. · Bone Marrow Transplantation · 16
Works count: 113
Citation count: 1,051
H-index: 18
I10-index: 36
Year
Topic
Type